Inventor · disambiguated record
Louis Crocker
Also filed as: CROCKER LOUIS · CROCKER LOUIS S
16 granted patents·6 pending applications·222 citations·filing 1996–2006
94Inventor score
Top patents by PatentIndex Score
22 records- 0195US6096742APolymorphic form of a tachykinin receptor antagonistMERCK & CO INC·Filed 1998·Granted Aug 1, 2000·77 cites·8 claims
- 0290US7145002B2Crystalline forms of carbapenem antibiotics and methods of preparationMERCK & CO INC·Filed 2002·Granted Dec 5, 2006·43 cites·6 claims
- 0389US6639071B2Crystal Forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-oneMERCK & CO INC·Filed 2001·Granted Oct 28, 2003·17 cites·11 claims
- 0488US6939964B2Crystal forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-oneMERCK & CO INC·Filed 2004·Granted Sep 6, 2005·15 cites·14 claims
- 0583US6583142B2Polymorphic form of a tachykinin receptor antagonistMERCK & CO INC·Filed 2002·Granted Jun 24, 2003·10 cites·11 claims
- 0679US7022841B2Process for making carbapenem compoundsMERCK & CO INC·Filed 2002·Granted Apr 4, 2006·14 cites·21 claims
- 0778US6432952B1Polymorphic form of a tachykinin receptor antagonistMERCK & CO INC·Filed 2000·Granted Aug 13, 2002·12 cites·14 claims
- 0877US6858631B1Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinylMERCK & CO INC·Filed 2003·Granted Feb 22, 2005·7 cites·5 claims
- 0977US6229010B1Polymorphic form of a tachykinin receptor antagonistMERCK & CO INC·Filed 1999·Granted May 8, 2001·15 cites·7 claims
- 1075US6441002B1Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonyphenyl)-6'- methyl-[2,3']bipyridinylMERCK & CO INC·Filed 2000·Granted Aug 27, 2002·4 cites·14 claims
- 1167US6538134B24-Benzyl-2-hydroxy-1,4-oxazine-3-one and polymorphic forms thereofMERCK & CO INC·Filed 2001·Granted Mar 25, 2003·3 cites·14 claims
- 1264USRE40794ECrystalline forms of carbapenem antibiotics and methods of preparationMERCK & CO INC·Filed 2002·Granted Jun 23, 2009·2 cites·6 claims
- 1361US6521642B25-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl in pure crystalline form and process for synthesisMERCK & CO INC·Filed 2001·Granted Feb 18, 2003·1 cites·14 claims
- 1461US6432953B2Polymorphic form of a tachykinin receptor antagonistMERCK & CO INC·Filed 2001·Granted Aug 13, 2002·1 cites·19 claims
- 1560US2003144327A1Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinylMERCK & CO INC·Filed 2003·Application pending·0 cites
- 1658US2006009641A1Crystal forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-oneCROCKER LOUIS S·Filed 2005·Application pending·0 cites
- 1758US2002198238A1Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinylMERCK & CO INC·Filed 2002·Application pending·0 cites
- 1851US6673935B25-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl in pure crystalline form and process for synthesisMERCK & CO INC·Filed 2003·Granted Jan 6, 2004·0 cites·8 claims
- 1951US2003208070A1Crystal forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-oneFiled 2003·Application pending·0 cites
- 2043US2008262029A1Acid and Base Salt Forms of GaboxadolLUNDBECK & CO AS H·Filed 2006·Application pending·0 cites
- 2137US5693812APolymorphic forms of an angiotensin II antagonistMERCK & CO INC·Filed 1996·Granted Dec 2, 1997·1 cites·22 claims
- 2233US2001016653A1Process for the crystallization of a reverse transcriptase inhibitor using an anti-solventFiled 1999·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →